Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 12.50
+0.07 (0.56%)
Oct 23, 2026, 3:00 PM CST
SHA:600557 Revenue
Jiangsu Kanion Pharmaceutical had revenue of 830.22M CNY in the quarter ending June 30, 2026, with 8.66% growth. This brings the company's total for the last twelve months to 3.31B, up 0.96% year-over-year. In the year 2025, Jiangsu Kanion Pharmaceutical had annual revenue of 3.29B, down -15.52%. That makes Jiangsu Kanion Pharmaceutical the 11,276th largest company in the world by revenue and 1,887th in China.
Revenue (ttm)
3.31B
Revenue Growth
+0.96%
P/S Ratio
2.14
Revenue / Employee
615.88K
Employees
5,379
Market Cap
7.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.29B | -604.77M | -15.52% |
| Dec 31, 2024 | 3.90B | -966.15M | -19.86% |
| Dec 31, 2023 | 4.86B | 512.95M | 11.79% |
| Dec 31, 2022 | 4.35B | 702.30M | 19.25% |
| Dec 31, 2021 | 3.65B | 616.64M | 20.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.